rs200865354

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_000719.7(CACNA1C):​c.5149G>A​(p.Ala1717Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000516 in 1,608,576 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A1717V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00028 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000027 ( 0 hom. )

Consequence

CACNA1C
NM_000719.7 missense

Scores

3
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 0.368

Publications

9 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
ITFG2-AS1 (HGNC:53128): (ITFG2 antisense RNA 1)
CACNA1C-AS1 (HGNC:40119): (CACNA1C antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.013155669).
BP6
Variant 12-2679501-G-A is Benign according to our data. Variant chr12-2679501-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 215771.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000282 (43/152256) while in subpopulation AFR AF = 0.000939 (39/41554). AF 95% confidence interval is 0.000705. There are 0 homozygotes in GnomAd4. There are 24 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 43 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000719.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1C
NM_000719.7
MANE Select
c.5149G>Ap.Ala1717Thr
missense
Exon 42 of 47NP_000710.5
CACNA1C
NM_001167623.2
MANE Plus Clinical
c.5149G>Ap.Ala1717Thr
missense
Exon 42 of 47NP_001161095.1Q13936-37
CACNA1C
NM_199460.4
c.5293G>Ap.Ala1765Thr
missense
Exon 44 of 50NP_955630.3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1C
ENST00000399603.6
TSL:5 MANE Plus Clinical
c.5149G>Ap.Ala1717Thr
missense
Exon 42 of 47ENSP00000382512.1Q13936-37
CACNA1C
ENST00000399655.6
TSL:1 MANE Select
c.5149G>Ap.Ala1717Thr
missense
Exon 42 of 47ENSP00000382563.1Q13936-12
CACNA1C
ENST00000682544.1
c.5383G>Ap.Ala1795Thr
missense
Exon 44 of 50ENSP00000507184.1A0A804HIR0

Frequencies

GnomAD3 genomes
AF:
0.000283
AC:
43
AN:
152138
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000941
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000659
AC:
16
AN:
242806
AF XY:
0.0000606
show subpopulations
Gnomad AFR exome
AF:
0.000759
Gnomad AMR exome
AF:
0.0000882
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000563
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000912
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000275
AC:
40
AN:
1456320
Hom.:
0
Cov.:
31
AF XY:
0.0000263
AC XY:
19
AN XY:
723668
show subpopulations
African (AFR)
AF:
0.000750
AC:
25
AN:
33322
American (AMR)
AF:
0.0000903
AC:
4
AN:
44318
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25962
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39550
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
85874
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52972
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5754
European-Non Finnish (NFE)
AF:
0.00000451
AC:
5
AN:
1108402
Other (OTH)
AF:
0.0000831
AC:
5
AN:
60166
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000282
AC:
43
AN:
152256
Hom.:
0
Cov.:
33
AF XY:
0.000322
AC XY:
24
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.000939
AC:
39
AN:
41554
American (AMR)
AF:
0.000196
AC:
3
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68014
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000264
Hom.:
0
Bravo
AF:
0.000287
ESP6500AA
AF:
0.00169
AC:
7
ESP6500EA
AF:
0.000119
AC:
1
ExAC
AF:
0.000124
AC:
15

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Cardiovascular phenotype (1)
-
-
1
Long QT syndrome (1)
-
1
-
not provided (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.066
CardioboostArm
Benign
0.0000011
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.31
CADD
Benign
19
DANN
Uncertain
0.99
DEOGEN2
Benign
0.0049
T
Eigen
Benign
-0.61
Eigen_PC
Benign
-0.52
FATHMM_MKL
Benign
0.69
D
M_CAP
Uncertain
0.14
D
MetaRNN
Benign
0.013
T
MetaSVM
Uncertain
-0.031
T
MutationAssessor
Benign
0.14
N
PhyloP100
0.37
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.46
N
REVEL
Benign
0.24
Sift
Benign
0.20
T
Sift4G
Benign
0.56
T
Polyphen
0.010
B
Vest4
0.085
MVP
0.60
MPC
0.18
ClinPred
0.022
T
GERP RS
-2.2
gMVP
0.42
Mutation Taster
=76/24
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200865354; hg19: chr12-2788667; COSMIC: COSV59700126; COSMIC: COSV59700126; API